Corvus: Q1 Earnings Snapshot
Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $7.9 million in its first quarter
By AP News
Published - May 08, 2023, 04:15 PM ET
Last Updated - Apr 05, 2024, 02:27 PM EDT
BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $7.9 million in its first quarter.
The Burlingame, California-based company said it had a loss of 17 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CRVS">Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS
